Atlas Trials

Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept

Clinical trial NCT01752049 · COMPLETED

Trial details

NCT number
NCT01752049
Sponsor
Unity Health Toronto
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hereditary Hemorrhagic Telangiectasia
Start date
2013-05-01
Primary completion
2019-08-30
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.